--- title: Evaluation of Sinetrol® Xpur in Fat Mass Reduction on Overweight and Obese Subjects nct_id: NCT04149158 overall_status: COMPLETED phase: NA sponsor: Fytexia study_type: INTERVENTIONAL primary_condition: Change in Total Body Fat Mass Percentage Loss Versus Body Weight countries: Spain canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04149158.md" clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04149158" ct_last_update_post_date: 2019-11-04 last_seen_at: "2026-05-12T07:31:24.685Z" source: ClinicalTrials.gov (mirrored, no enrichment) --- # Evaluation of Sinetrol® Xpur in Fat Mass Reduction on Overweight and Obese Subjects **NCT ID:** [NCT04149158](https://clinicaltrials.gov/study/NCT04149158) ## Key Facts - **Status:** COMPLETED - **Phase:** NA - **Study Type:** INTERVENTIONAL - **Target Enrollment:** 77 - **Lead Sponsor:** Fytexia - **Conditions:** Change in Total Body Fat Mass Percentage Loss Versus Body Weight - **Start Date:** 2015-04 - **Completion Date:** 2017-09 - **CT.gov Last Update:** 2019-11-04 ## Brief Summary This study aims to evaluate effects of a 16-week supplementation with a polyphenol rich extract, Sinetrol® Xpur, on fat mass accumulation and body weight management improvement.Subjects were overweight or obese and received polyphenol supplement or placebo. A 4-week follow-up as performed to evaluate its effect after supplementation stop. ## Eligibility - **Minimum age:** 25 Years - **Maximum age:** 55 Years - **Sex:** ALL - **Healthy Volunteers:** Yes ``` Inclusion Criteria: * overweight or obese (25 kg.m-2\